A new era of psychedelics is here, one steeped in science and progress. Scientists at prestigious research institutions are conducting rigorous studies on using psychedelic-assisted therapies to treat mental health issues, and so far the results have been remarkably promising.
But in order to build on their momentum and to see their work through to medicalization, these government-approved trials must receive a continuous influx of money — yet for political and profit reasons, no federal agency or pharmaceutical company will fund them..
That’s why we started Fundamental, the first-ever campaign to finance medical research through crowdfunding. We’re giving everyone the chance to contribute to these incredible studies:
- Psilocybin treatment for end-of-life distress in patients with life-threatening cancer, led by NYU School of Medicine’s Dr. Stephen Ross
- Psilocybin treatments for addiction, led by NYU School of Medicine’s Dr. Michael Bogenschutz
- MDMA treatment for PTSD patients, led by Multidisciplinary Association for Psychedelic Studies (MAPS) founder & executive director Dr. Rick Doblin
- Microdosing with LSD for cognitive enhancement, led by Beckley Foundation Founder & Director Amanda Feilding
Now anyone can directly contribute to finding a solution for America’s mental health crisis. That includes you. Join the mental health revolution at fundamental.nyc.